Anticancer behaviour of 2,2′-(pyridin-2-ylmethylene)bis(5,5-dimethylcyclohexane-1,3-dione)-based palladium(II) complex and its DNA, BSA binding propensity and DFT study.

MLA

Ragheb, Mohamed A., et al. “Anticancer Behaviour of 2,2′-(Pyridin-2-Ylmethylene)Bis(5,5-Dimethylcyclohexane-1,3-Dione)-Based Palladium(II) Complex and Its DNA, BSA Binding Propensity and DFT Study.” Journal of Inorganic Biochemistry, vol. 253, Apr. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jinorgbio.2024.112488.

APA

Ragheb, M. A., Soliman, M. H., Abdelhamid, I. A., Shoukry, M. M., Haukka, M., & Ragab, M. S. (2024). Anticancer behaviour of 2,2′-(pyridin-2-ylmethylene)bis(5,5-dimethylcyclohexane-1,3-dione)-based palladium(II) complex and its DNA, BSA binding propensity and DFT study. Journal of Inorganic Biochemistry, 253, N.PAG. https://doi.org/10.1016/j.jinorgbio.2024.112488

Chicago

Ragheb, Mohamed A., Marwa H. Soliman, Ismail A. Abdelhamid, Mohamed M. Shoukry, Matti Haukka, and Mona S. Ragab. 2024. “Anticancer Behaviour of 2,2′-(Pyridin-2-Ylmethylene)Bis(5,5-Dimethylcyclohexane-1,3-Dione)-Based Palladium(II) Complex and Its DNA, BSA Binding Propensity and DFT Study.” Journal of Inorganic Biochemistry 253 (April): N.PAG. doi:10.1016/j.jinorgbio.2024.112488.